Since 1984, MEDTOX has been developing innovative products and in 1987, MEDTOX developed the first FDA 510(k)-cleared diagnostics drug-screening device. Since then, MEDTOX has received FDA 510(k)-clearance on numerous drug-screening devices. All MEDTOX devices are subjected to a strict internal QC/QA process – their performance is measured through ongoing comparison with CAP UDS proficiency specimens.
The system includes the PROFILE®-V MEDTOXScan Test Device and the MEDTOXScan®Reader, which interprets and reports the test results automatically. The test menu is comprehensive with a panel of 12 drugs providing single sample testing to a broad range of drugs. The PROFILE®-V device offers screening results in 10 minutes. Devices are activated by the tester pipetting urine into the sample wells.
Substances Tested For:
- AMP Amphetamine
- BAR Barbiturates
- BZO Benzodiazepines
- COC Cocaine
- MAMP Methamphetamine
- MTD Methadone
- OPI Opiates
- OXY Oxycodone
- PCP Phencyclidine
- PPX Propoxyphene
- THC Cannabinoids
- TCA Tricyclic Antidepressants
The next generation in hospital laboratory drug screening:
- Easy installation and operation
- One-step testing process
- Results in ten minutes
- Lower clinical cut-off levels
- Stores up to 1000 results.
- Eliminates operator result interpretation
- Can test up to 12 drugs, including Methamphetamine and Oxycodone
- Ability to report into hospital LIS